Behavioral effects of short-term administration of lithium and valproic acid in rats

被引:33
作者
Tomasiewicz, Hilarie C. [1 ]
Mague, Stephen D. [1 ]
Cohen, Bruce M. [1 ]
Carlezon, William A., Jr. [1 ]
机构
[1] Harvard Univ, Sch Med, McLean Hosp, Behav Genet Lab,Dept Psychiat, Belmont, MA 02478 USA
关键词
mood stabilizer; bipolar disorder; depression; mania; model; rat;
D O I
10.1016/j.brainres.2006.03.102
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Lithium and valproic acid are mood-stabilizing agents that are often used to manage the episodes of mania and depression that characterize bipolar disorder. These agents develop clinical efficacy with chronic treatment, but the neurobiological actions that contribute to their therapeutic effects remain unclear. The present work was designed to study and compare various behavioral effects of short-term administration of lithium chloride (LiCl) and valproic acid (VPA) in rats. Specifically, we examined the effects of acute and sub-acute injections of these agents on locomotor activity, behavior in the forced swim test (FST), and intracranial self-stimulation (ICSS) thresholds. Locomotor activity studies were used to identify the range of doses with gross behavioral effects in rats. At doses below those that suppressed activity (total distance traveled, in cm) in 1-h test sessions, LiCl had prodepressant-like effects: it increased immobility in the FST, an effect opposite to that typically seen with standard antidepressants, and it increased ICSS thresholds, an effect similar to that typically seen during withdrawal from drugs of abuse. In contrast, VPA had no effects in the FST or on ICSS thresholds. This work identifies potentially important characteristics that distinguish the drugs at doses below those that produce non-specific behavioral effects, and thus serves as a basis for designing and interpreting studies of long-term treatment. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:83 / 94
页数:12
相关论文
共 57 条
[2]   Treatment research in bipolar disorder - Issues and recommendations [J].
Baldessarini, RJ .
CNS DRUGS, 2002, 16 (11) :721-729
[3]   A 'crash' course on psychostimulant withdrawal as a model of depression [J].
Barr, AM ;
Markou, A ;
Phillips, AG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (10) :475-482
[4]   Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants: Possible roles of serotoninergic systems [J].
Bourin, M ;
Hascoet, M ;
Colombel, MC ;
Redrobe, JP ;
Baker, GB .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1996, 6 (03) :231-236
[5]  
BOWDEN CL, 1995, J CLIN PSYCHIAT, V56, P25
[6]   SPECTRUM OF EFFICACY OF VALPROATE IN 78 RAPID-CYCLING BIPOLAR PATIENTS [J].
CALABRESE, JR ;
MARKOVITZ, PJ ;
KIMMEL, SE ;
WAGNER, SC .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1992, 12 (01) :S53-S56
[8]   Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? [J].
Carlezon, WA ;
Nestler, EJ .
TRENDS IN NEUROSCIENCES, 2002, 25 (12) :610-615
[9]   Repeated exposure to rewarding brain stimulation downregulates GluR1 expression in the ventral tegmental area [J].
Carlezon, WA ;
Todtenkopf, MS ;
McPhie, DL ;
Pimentel, P ;
Pliakas, AM ;
Stellar, JR ;
Trzcinska, M .
NEUROPSYCHOPHARMACOLOGY, 2001, 25 (02) :234-241
[10]   Depressive-like effects of the κ-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats [J].
Carlezon, WA ;
Béguin, C ;
DiNieri, JA ;
Baumann, MH ;
Richards, MR ;
Todtenkopf, MS ;
Rothman, RB ;
Ma, ZZ ;
Lee, DYW ;
Cohen, BM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (01) :440-447